Phase II trial of neoadjuvant Alimta [pemetrexed] plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma.
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Pemetrexed (Primary) ; Cisplatin
- Indications Malignant-mesothelioma
- Focus Therapeutic Use
- 09 Mar 2010 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.
- 09 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Dec 2009 Planned end date changed from 1 Mar 2009 to 1 Jan 2010 as reported by ClinicalTrials.gov.